Protalix BioTherapeutics, Inc. (AMEX:PLX)
CAPS Rating:
A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.
RSS Headlines
Fool UK